[ON THE PERORAL THERAPY OF THE STEIN-LEVENTHAL SYNDROME WITH 16-METHYLENE-6-DEHYDRO-17-ALPHA-ACETOXYPROGESTERON].
D004358:Drug Therapy; D005260:Female; D006801:Humans; D008697:Methane / Q000031:analogs & derivatives; D011085:Polycystic Ovary Syndrome; D011372:Progestins; D014116:Toxicology
D011372:Progestins; C030011:carbene; D008697:Methane
DRUG THERAPY; PROGESTATIONAL HORMONES; STEIN-LEVENTHAL SYNDROME; TOXICOLOGIC REPORT
UBER DIE PERORALE THERAPIE DES STEIN-LEVENTHAL-SYNDROME MIT 16-METHYLEN-6-DEHYDRO-17-ALPHA-AZETOXYPROGESTERON.